Clinical Developments in Allergen Immunotherapy
description
Transcript of Clinical Developments in Allergen Immunotherapy
![Page 1: Clinical Developments in Allergen Immunotherapy](https://reader036.fdocuments.in/reader036/viewer/2022081507/56815ed4550346895dcd6cd5/html5/thumbnails/1.jpg)
Clinical Developments in Allergen Immunotherapy
![Page 2: Clinical Developments in Allergen Immunotherapy](https://reader036.fdocuments.in/reader036/viewer/2022081507/56815ed4550346895dcd6cd5/html5/thumbnails/2.jpg)
![Page 3: Clinical Developments in Allergen Immunotherapy](https://reader036.fdocuments.in/reader036/viewer/2022081507/56815ed4550346895dcd6cd5/html5/thumbnails/3.jpg)
Allergen Immunotherapy (AI) Overview
![Page 4: Clinical Developments in Allergen Immunotherapy](https://reader036.fdocuments.in/reader036/viewer/2022081507/56815ed4550346895dcd6cd5/html5/thumbnails/4.jpg)
AI Overview (cont)
![Page 5: Clinical Developments in Allergen Immunotherapy](https://reader036.fdocuments.in/reader036/viewer/2022081507/56815ed4550346895dcd6cd5/html5/thumbnails/5.jpg)
Recent Developments in AI
![Page 6: Clinical Developments in Allergen Immunotherapy](https://reader036.fdocuments.in/reader036/viewer/2022081507/56815ed4550346895dcd6cd5/html5/thumbnails/6.jpg)
Cox et al Study of a 5-grass Pollen Sublingual Tablet
![Page 7: Clinical Developments in Allergen Immunotherapy](https://reader036.fdocuments.in/reader036/viewer/2022081507/56815ed4550346895dcd6cd5/html5/thumbnails/7.jpg)
Primary Efficacy Data From 3 Studies of Grass Sublingual Tablet
![Page 8: Clinical Developments in Allergen Immunotherapy](https://reader036.fdocuments.in/reader036/viewer/2022081507/56815ed4550346895dcd6cd5/html5/thumbnails/8.jpg)
Blaiss et al Study of Grass Pollen Sublingual Tablet
![Page 9: Clinical Developments in Allergen Immunotherapy](https://reader036.fdocuments.in/reader036/viewer/2022081507/56815ed4550346895dcd6cd5/html5/thumbnails/9.jpg)
Blaiss et al Study of Grass Pollen Sublingual Tablet (cont)
![Page 10: Clinical Developments in Allergen Immunotherapy](https://reader036.fdocuments.in/reader036/viewer/2022081507/56815ed4550346895dcd6cd5/html5/thumbnails/10.jpg)
Primary Efficacy Data From 2 Studies of Ragweed Sublingual
Tablet
![Page 11: Clinical Developments in Allergen Immunotherapy](https://reader036.fdocuments.in/reader036/viewer/2022081507/56815ed4550346895dcd6cd5/html5/thumbnails/11.jpg)
Ragweed Sublingual Tablet for AI
![Page 12: Clinical Developments in Allergen Immunotherapy](https://reader036.fdocuments.in/reader036/viewer/2022081507/56815ed4550346895dcd6cd5/html5/thumbnails/12.jpg)
Reduction in TCS During Peak Ragweed Season
![Page 13: Clinical Developments in Allergen Immunotherapy](https://reader036.fdocuments.in/reader036/viewer/2022081507/56815ed4550346895dcd6cd5/html5/thumbnails/13.jpg)
Where Sublingual AI Stands in the US
![Page 14: Clinical Developments in Allergen Immunotherapy](https://reader036.fdocuments.in/reader036/viewer/2022081507/56815ed4550346895dcd6cd5/html5/thumbnails/14.jpg)
A Study of Sublingual Liquid AI
![Page 15: Clinical Developments in Allergen Immunotherapy](https://reader036.fdocuments.in/reader036/viewer/2022081507/56815ed4550346895dcd6cd5/html5/thumbnails/15.jpg)
Results
![Page 16: Clinical Developments in Allergen Immunotherapy](https://reader036.fdocuments.in/reader036/viewer/2022081507/56815ed4550346895dcd6cd5/html5/thumbnails/16.jpg)
Safety of Subcutaneous AI
![Page 17: Clinical Developments in Allergen Immunotherapy](https://reader036.fdocuments.in/reader036/viewer/2022081507/56815ed4550346895dcd6cd5/html5/thumbnails/17.jpg)
Safety of Sublingual AI (cont)
![Page 18: Clinical Developments in Allergen Immunotherapy](https://reader036.fdocuments.in/reader036/viewer/2022081507/56815ed4550346895dcd6cd5/html5/thumbnails/18.jpg)
Safety of Sublingual AI (cont)
![Page 19: Clinical Developments in Allergen Immunotherapy](https://reader036.fdocuments.in/reader036/viewer/2022081507/56815ed4550346895dcd6cd5/html5/thumbnails/19.jpg)
Safety of Sublingual AI (cont)
![Page 20: Clinical Developments in Allergen Immunotherapy](https://reader036.fdocuments.in/reader036/viewer/2022081507/56815ed4550346895dcd6cd5/html5/thumbnails/20.jpg)
Studies Directly Comparing SLIT and SCIT Adherencea
![Page 21: Clinical Developments in Allergen Immunotherapy](https://reader036.fdocuments.in/reader036/viewer/2022081507/56815ed4550346895dcd6cd5/html5/thumbnails/21.jpg)
Monophosphoryl Lipid A (MPLA)
![Page 22: Clinical Developments in Allergen Immunotherapy](https://reader036.fdocuments.in/reader036/viewer/2022081507/56815ed4550346895dcd6cd5/html5/thumbnails/22.jpg)
MPLA (cont)
![Page 23: Clinical Developments in Allergen Immunotherapy](https://reader036.fdocuments.in/reader036/viewer/2022081507/56815ed4550346895dcd6cd5/html5/thumbnails/23.jpg)
Ultrashort-specific Immunotherapy for Seasonal Allergic Rhinoconjunctivitis Caused
by Grass Pollen
![Page 24: Clinical Developments in Allergen Immunotherapy](https://reader036.fdocuments.in/reader036/viewer/2022081507/56815ed4550346895dcd6cd5/html5/thumbnails/24.jpg)
Ultrashort-specific Immunotherapy (cont)
![Page 25: Clinical Developments in Allergen Immunotherapy](https://reader036.fdocuments.in/reader036/viewer/2022081507/56815ed4550346895dcd6cd5/html5/thumbnails/25.jpg)
Abbreviations
![Page 26: Clinical Developments in Allergen Immunotherapy](https://reader036.fdocuments.in/reader036/viewer/2022081507/56815ed4550346895dcd6cd5/html5/thumbnails/26.jpg)
References
![Page 27: Clinical Developments in Allergen Immunotherapy](https://reader036.fdocuments.in/reader036/viewer/2022081507/56815ed4550346895dcd6cd5/html5/thumbnails/27.jpg)
References (cont)
![Page 28: Clinical Developments in Allergen Immunotherapy](https://reader036.fdocuments.in/reader036/viewer/2022081507/56815ed4550346895dcd6cd5/html5/thumbnails/28.jpg)
References (cont)
![Page 29: Clinical Developments in Allergen Immunotherapy](https://reader036.fdocuments.in/reader036/viewer/2022081507/56815ed4550346895dcd6cd5/html5/thumbnails/29.jpg)
References (cont)